NCT03366610View on ClinicalTrials.gov

Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based Regimens

CompletedOBSERVATIONAL
Enrollment

199

Participants

Timeline

Start Date

April 28, 2017

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Hepatitis C
Interventions
OTHER

Non-interventional

Non-interventional

Trial Locations (1)

Unknown

Local Institution, Beijing

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY

NCT03366610 - Study to Assess Clinical Outcomes in Chronic Hepatitis C Patients Previously Treated With Daclatasvir-Based Regimens | Biotech Hunter | Biotech Hunter